| The NLVPMVATV peptide is a well-characterized epitope derived from the pp65 protein of human cytomegalovirus (HCMV). This peptide is presented by HLA-A*02:01 molecules and is recognized by CD8+ cytotoxic T lymphocytes (CTLs). Due to its immunodominance, NLVPMVATV is widely used in immunological studies to monitor CMV-specific T-cell responses, especially in immunocompromised individuals such as transplant recipients. Its consistent recognition across different individuals makes it a valuable tool in vaccine development and adoptive T-cell therapies. |
